The company LumeNXT Incorporated has named its newest member of the organization. Recently, it named longtime executive Marc Beer as its new Chairman of the Board. Beer will be joining a privately held company that focuses on developing specialized surgical illumination products. The products are used to perform minimally invasive surgeries. Once joining LumeN XT, Marc will bring his expertise and over two decades of experience in biotechnology, pharmaceuticals and medical device technology to LumeN XT.
Shortly after being named as the new chairman of LumeN XT, Marc Beer said that he is very proud to be working with a group of surgeons and engineers who are dedicated to using surgical illumination technology in order to perform surgery that is minimally invasive. He also said that he believes in the importance of the technology and products provided by LumeN XT as it will help enhance the effectiveness of minimally invasive surgical procedures.
It has been known that surgeons that use targeted illumination often find out that the technology helps enhance the vision, precision and flexibility whenever an operation is performed. As a result, it is a superior option compared to more traditional surgical techniques and approaches. LumeN XT has the distinct advantage of using advanced illumination that uses heat reduction. This helps improve the surgical precision as well as reducing costs.
The co founder of LumeN XT Paul Rhyne has said that Marc has been able to demonstrate a high level of success with numerous startup companies in the healthcare industry. He has been known to guide companies in a number of different phases or growth. Rhyne also said that Marc Beer has established a lot of experience in starting up companies and guiding them through the process of global growth as well as increasing their profitability.
Prior to joining LumeN XT, Marc Beer has spent the last few years as the founding chairman and chief executive officer of Renovia Incorporated. That company’s mission was to both discover and deliver a line of therapeutic devices. These devices were used to help treat pelvic floor disorders that women experience. Before founding and managing Renovia, Marc was the founder and chairman of another company called Minerva Neurosciences Incorporated. This company was one that provided clinical stage biopharmaceuticals. It developed products to help treat a number of disorders of the central nervous system. The company worked towards developing therapeutic options to psychological conditions such as insomnia, depression and schizophrenia. Learn more: http://professionaltales.com/the-voice-of-marc-beer-how-to-be-a-good-leader/
Throughout his career, Marc Beer has been involved in helping a number of biotechnology and healthcare companies become successful organizations. He was also actively involved in working in the biopharmaceutical field in which he looked to treat diseases and facilitate growth by issuing initial public offerings. Throughout his career, Marc has demonstrated valuable leadership skills that helped many companies reach their full potential.